Show simple item record

Campbell/Spillane Substance Use Research - Interview with Clifton Himmelsbach

dc.contributor.authorJon Harkness, Gail Javitt
dc.date.accessioned2024-04-19T20:13:14Z
dc.date.available2024-04-19T20:13:14Z
dc.date.issued1994-11-02en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/192804
dc.description.abstractAs a clinical investigator with the U.S. Public Health Service during the 1930s, Clifton Himmelsbach, M.D., directed the laboratory at the Fort Leavenworth Penitentiary Annex in 1933-34 before establishing the laboratory at the Lexington Narcotics Hospital in 1935. In his early work, Himmelsbach systematically observed and charted withdrawal and abstinence symptoms, thereby laying the foundation for assessing the addictive potential of drugs. An advocate of a multi-disciplinary approach to the problem of addiction, Himmelsbach fostered a unique experimental climate at Lexington, encouraging collaboration and synergistic thinking among the scientists. Dr. Himmelsbach also pioneered the concept of informed consent; he argued that the addicts who served as human subjects in the research at Lexington had much to contribute to the research, often teaching the scientists about drug-taking practices, and that human subjects could gain satisfaction from participating in clinical research. Dr. Himmelsbach died in 1995. Sources: Transcript. “Clifton Keck Himmelsbach” FindAGrave.com. https://www.findagrave.com/memorial/53659947/clifton-keck-himmelsbach Accessed 18 Oct 2021. NIH: https://history.nih.gov/display/history/Synthetic+Opiates Accessed 04 Feb 2023
dc.description.sponsorshipNational Science Foundation; College on Problems of Drug Dependence; University of Michigan Substance Abuse Research Center; University of Michigan Institute for Research on Women and Gender; Wayne State University; University of Florida College of Liberal Arts and Sciences
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAbuse liability; Addiction; Addiction neuroscience; Addiction research; Behavioral pharmacology; Drug abuse; Drug dependence; Ethics of addiction research; Medication assisted treatment; Substance abuse disorder; Substance abuse treatment
dc.titleCampbell/Spillane Substance Use Research - Interview with Clifton Himmelsbach
dc.typeImage; Interview; Recording, oral
dc.subject.hlbsecondlevelHealth behavior and health education; History
dc.subject.hlbtoplevelHumanities
dc.subject.hlbtoplevelHealth Sciences
dc.contributor.affiliationumSchool of Nursing
dc.contributor.affiliationumCenter for the Study of Drugs, Alcohol, Smoking and Health (DASH Center)
dc.contributor.affiliationumcampusAnn Arbor
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/192804/1/Himmelsbach_Clifton_bio.docx
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/192804/2/Himmelsbach_Clifton_photo.jpg
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/192804/3/Himmelsbach_Clifton_transcript_14.docx
dc.identifier.doihttps://dx.doi.org/10.7302/22536
dc.working.doi10.7302/22536en
dc.owningcollnamePathways of Public Science


Files in this item

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.